| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/4/264:05 PM | -$0.10 | -$0.13 | -29.0% | +14% | $71.6M | $83.9M | +17.1% | -11% | |
| Q2 '26 | 7/29/264:05 PM | -$0.13 | -$0.10 | +23.1% | +41% | $66.1M | $71.6M | +8.3% | +22% | |
| Q1 '26 | 5/5/264:05 PM | -$0.16 | -$0.13GAAP | +18.8% | +35% | $61.1M | $70.9M | +16.0% | +35% | |
| Q4 '25 | 2/5/264:05 PM | -$0.19 | -$0.09GAAP | +52.6% | +61% | $60.9M | $71.7M | +17.7% | +51% | |
| Q3 '25 | 11/5/254:05 PM | -$0.15 | -$0.15 | 0.0% | +32% | $66.0M | $60.2M | -8.8% | +30% | |
| Q2 '25 | 8/5/254:05 PM | -$0.24 | -$0.17GAAP | +29.2% | +45% | $49.5M | $58.9M | +18.9% | +36% | |
| Q1 '25 | 5/1/254:05 PM | -$0.31 | -$0.20GAAP | +35.5% | +39% | $42.1M | $52.4M | +24.4% | +25% |
GAAP = diluted EPS as filed with the SEC. Other EPS figures are adjusted (non-GAAP), the basis analysts estimate.